Late Breaking Abstract - Daily physical activity in patients with severe asthma and the effect of anti-IL5 therapy

被引：2
|
作者：
Panagiotou, Marios [1 ]
Koulouris, Nikolaos [1 ]
Koutsoukou, Antonia [1 ]
Tsami, Maria [2 ]
Syrigou, Ekaterini [3 ]
Rovina, Nikoletta [1 ]
机构：
[1] Univ Athens, Dept Resp Med 1, Sotiria Thorac Dis Gen Hosp, Athens, Greece
[2] Sotiria Gen Hosp, Dept Allergy & Clin Immunol, Athens, Greece
[3] Sotiria Gen Hosp, Dept Allergy & Clin Immunol, Athens, Greece
来源：
EUROPEAN RESPIRATORY JOURNAL | 2019年 / 54卷
关键词：
Asthma; -; management; Physical activity; Adults;
D O I：
10.1183/13993003.congress-2019.PA1648
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
PA1648
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Effect of Anti-IL5, Anti-IL5R, Anti-IL13 Therapy on Asthma Exacerbations: A Network Meta-analysis
    Richard P. Ramonell
    Imran H. Iftikhar
    Lung, 2020, 198 : 95 - 103
  • [32] Evaluation of therapeutic response to anti-IL5 treatment in severe eosinophilic asthma patients no responders to omalizumab
    Laorden Escudero, Daniel
    Zamarron De Lucas, Ester
    Romero Ribate, David
    Fernandez Lahera, Juan
    Garcia Rio, Francisco
    Villasante Fernandez, Carlos
    Alvarez-Sala Walther, Rodolfo
    Quirce Gancedo, Santiago
    Padilla Brito, Jose Manuel
    Barranco Sanz, Pilar
    EUROPEAN RESPIRATORY JOURNAL, 2019, 54
  • [33] Changes in Type 2 Biomarkers After Anti-IL5 Treatment in Patients With Severe Eosinophilic Asthma
    Jang, Jae-Hyuk
    Woo, Seong-Dae
    Lee, Youngsoo
    Kim, Chang-Keun
    Shin, Yoo Seob
    Ye, Young-Min
    Park, Hae-Sim
    ALLERGY ASTHMA & IMMUNOLOGY RESEARCH, 2021, 13 (02) : 330 - 338
  • [34] Anti-IL5 therapy could prevent lung function decline in severe eosinophilic asthma: data from the belgian severe asthma registry
    Graff, Sophie
    Brusselle, Guy
    Hanon, Shane
    Sohy, Carine
    Dupont, Lieven
    Peche, Rudi
    Michils, Alain
    Pilette, Charles
    Joos, Guy
    Louis, Renaud
    Schleich, Florence
    EUROPEAN RESPIRATORY JOURNAL, 2021, 58
  • [35] Effects of anti-IL5 receptor a in severe asthma: a real-life study
    Ardesi, Francesco
    Zappa, Martina
    Pignatti, Patrizia
    Grossi, Sarah
    Centis, Rosella
    Visca, Dina
    Spanevello, Antonio
    EUROPEAN RESPIRATORY JOURNAL, 2023, 62
  • [36] Late Breaking Abstract - Patients with severe eosinophilic asthma benefit from the treatment with Anti-IL-5 Reslizumab - a real life study from Austria
    Marth, Katharina
    Renner, Andreas
    Patocka, Karin
    Pohl, Wolfgang
    EUROPEAN RESPIRATORY JOURNAL, 2018, 52
  • [37] Adherence to Criteria to Continue Targeted Anti-IL5 Therapy in Severe Refractory Eosinophilic Asthma at 12 Months
    McLaughlin, Patricia
    Mikulich, Olga
    Rajan, Mathew
    IRISH JOURNAL OF MEDICAL SCIENCE, 2024, 193 : S217 - S217
  • [38] Anti-IL5 mepolizumab minimally influences residual blood eosinophils in severe asthma
    Van Hulst, Glenn
    Jorssen, Joseph
    Jacobs, Nathalie
    Henket, Monique
    Louis, Renaud
    Schleich, Florence
    Bureau, Fabrice
    Desmet, Christophe J.
    EUROPEAN RESPIRATORY JOURNAL, 2022, 59 (03)
  • [39] Comparative effectiveness of Anti-IL5 and Anti-IgE biologic classes in patients with severe asthma eligible for both
    Pfeffer, Paul E.
    Ali, Nasloon
    Murray, Ruth
    Ulrik., Charlotte
    Tran, Trung N.
    Maspero, Jorge
    Peters, Matthew
    Christoff, George C.
    Sadatsafavi, Mohsen
    Torres-Duque, Carlos A.
    Altraja, Alan
    Lehtimaki, Lauri
    Papadopoulos, Nikolaos G.
    Salvi, Sundeep
    Costello, Richard W.
    Cushen, Breda
    Heffler, Enrico
    Iwanaga, Takashi
    Al-Ahmad, Mona
    Larenas-Linnemann, Desiree
    Kuna, Piotr
    Fonseca, Joao A.
    Al-Lehebi, Riyad
    Rhee, Chin Kook
    Perez-de-Llano, Luis
    Perng Steve, Diahn-Warng
    Mahboub, Bassam
    Wang, Eileen
    Goh, Celine
    Lyu, Juntao
    Newell, Anthony
    Alacqua, Marianna
    Belevskiy, Andrey S.
    Bhutani, Mohit
    Bjermer, Leif
    Bjornsdottir, Unnur
    Bourdin, Arnaud
    von Boulow, Anna
    Busby, John
    Canonica, Giorgio Walter
    Cosio, Borja G.
    Dorscheid, Delbert R.
    Munoz-Esquerre, Mariana
    FitzGerald, J. Mark
    Gil, Esther Garcia
    Gibson, Peter G.
    Heaney, Liam G.
    Hew, Mark
    Hilberg, Ole
    Hoyte, Flavia
    ALLERGY, 2023, 78 (07) : 1934 - 1948
  • [40] Real-life biomarker response to anti-IL5 and anti-IgE therapies in severe asthma patients
    Burkill, S.
    Porsbjerg, C. M.
    Bourdin, A.
    Tran, T. N.
    Martin, N.
    Katial, R.
    Barker, P.
    Wechsler, M. E.
    Maspero, J.
    Bosnic-Anticevich, S.
    Chung, L. P.
    Katsoulotos, G.
    Christoff, G. C.
    Popov, T. A.
    Sadatsafavi, M.
    Torres-Duque, C. A.
    Ulrik, C.
    Assing, K. Dahl
    Hansen, S.
    Altraja, A.
    Lehtimaki, L. A.
    Papadopoulos, N. G.
    Kostikas, K.
    Salvi, S.
    Costello, R. W.
    Francesca, P.
    Iwanaga, T.
    Rhee, C. K.
    Al-Ahmad, M.
    Larenas-Linnemann, D.
    Fonseca, J. A.
    Amaral, R.
    Alving, K.
    Al-Lehebi, R.
    De-Llano, L. Perez
    Kirenga, B.
    Tsai, M.
    Mahboub, B.
    Pfeffer, P. E.
    Henley, W.
    Liu, Y.
    Lyu, J.
    Goh, C.
    Uthaman, T.
    Price, D.
    Townend, J.
    EUROPEAN RESPIRATORY JOURNAL, 2022, 60
12345